Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker

Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker

Blog Article

The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases.It is of concern whether all potential undesired Bile Acid complications of therapy have been evaluated within clinical trials which have led to treatment approval.Specialists prescribing TNF blockers should be aware of the unusual and severe complications that can occur.We describe a case of endogenous endophthalmitis AEG BS831410KM ProCombi Steam Oven in a rheumatoid patient on TNF alpha blocker.